Education
About Us
Working with TipRanks
Follow Us
Atlantic International (ATLN)
NASDAQ:ATLN
RESEARCH TOOLSreports
ATLN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.68 - $7.97
Previous Close$6.28
Volume7.10K
Average Volume (3M)53.77K
Market Cap
$131.32M
Enterprise Value$4.21M
Total Cash (Recent Filing)$678.68K
Total Debt (Recent Filing)$82.72M
Price to Earnings (P/E)―
Beta0.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.27
Shares Outstanding61,650,547
10 Day Avg. Volume114,284
30 Day Avg. Volume53,774
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)0.79
Price to Sales (P/S)0.00
P/FCF Ratio-0.93
Enterprise Value/Market Cap0.03
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit0.12
Enterprise Value/Ebitda-0.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Atlantic International News
PremiumCompany Announcements
Atlantic International Secures $70M Credit Facility
PremiumCompany Announcements
Atlantic International Ends Merger with Staffing 360Options Prices
Currently, No data available
---
Ownership Overview
65.67% Insiders
0.31%
Mutual Funds
― Other Institutional Investors
33.72% Public Companies and Individual Investors
ATLN FAQ
What was Atlantic International’s price range in the past 12 months?
Atlantic International lowest stock price was $1.68 and its highest was $7.97 in the past 12 months.
What is Atlantic International’s market cap?
Atlantic International’s market cap is $131.32M.
When is Atlantic International’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Atlantic International’s earnings last quarter?
Atlantic International released its earnings results on May 09, 2023. The company reported -$5.2 earnings per share for the quarter, missing the consensus estimate of N/A by -$5.2.
Is Atlantic International overvalued?
According to Wall Street analysts Atlantic International’s price is currently Overvalued.
Does Atlantic International pay dividends?
Atlantic International does not currently pay dividends.
What is Atlantic International’s EPS estimate?
Atlantic International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Atlantic International have?
Atlantic International has 61,650,547 shares outstanding.
What happened to Atlantic International’s price movement after its last earnings report?
Atlantic International reported an EPS of -$5.2 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.746%.
Which hedge fund is a major shareholder of Atlantic International?
Currently, no hedge funds are holding shares in ATLN
Atlantic International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.27%
12-Months-Change
Fundamentals
Return on Equity
-715.34%
Trailing 12-Months
Asset Growth
3073.93%
Trailing 12-Months
Company Description
Atlantic International
As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provides solutions for various applications, such as biomarker discovery and diagnostic assay developments, including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and Weizmann Institute of Science for developed and applied innovative single-molecule technologies. The company was formerly known as SeqLL Inc. and changed its name to Atlantic International Corp. in June 2024. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.